133 related articles for article (PubMed ID: 28422732)
1. Molecular and serologic markers of HPV 16 infection are associated with local recurrence in patients with oral cavity squamous cell carcinoma.
Huang CG; Lee LA; Liao CT; Yen TC; Yang SL; Liu YC; Li JC; Gong YN; Kang CJ; Huang SF; Fang KH; Chang KP; Lee LY; Hsueh C; Shih SR; Tsao KC
Oncotarget; 2017 May; 8(21):34820-34835. PubMed ID: 28422732
[TBL] [Abstract][Full Text] [Related]
2. Decreased HPV-specific T cell responses and accumulation of immunosuppressive influences in oropharyngeal cancer patients following radical therapy.
Al-Taei S; Banner R; Powell N; Evans M; Palaniappan N; Tabi Z; Man S
Cancer Immunol Immunother; 2013 Dec; 62(12):1821-30. PubMed ID: 24146146
[TBL] [Abstract][Full Text] [Related]
3. Morphoproteomics, E6/E7 in-situ hybridization, and biomedical analytics define the etiopathogenesis of HPV-associated oropharyngeal carcinoma and provide targeted therapeutic options.
Brown RE; Naqvi S; McGuire MF; Buryanek J; Karni RJ
J Otolaryngol Head Neck Surg; 2017 Aug; 46(1):52. PubMed ID: 28818106
[TBL] [Abstract][Full Text] [Related]
4. Identification of antibodies against human papillomavirus type 16 E6 and E7 proteins in sera of patients with cervical neoplasias.
Sasagawa T; Inoue M; Tanizawa O; Yutsudo M; Hakura A
Jpn J Cancer Res; 1992 Jul; 83(7):705-13. PubMed ID: 1325428
[TBL] [Abstract][Full Text] [Related]
5. Kinetics of the Human Papillomavirus Type 16 E6 Antibody Response Prior to Oropharyngeal Cancer.
Kreimer AR; Johansson M; Yanik EL; Katki HA; Check DP; Lang Kuhs KA; Willhauck-Fleckenstein M; Holzinger D; Hildesheim A; Pfeiffer R; Williams C; Freedman ND; Huang WY; Purdue MP; Michel A; Pawlita M; Brennan P; Waterboer T
J Natl Cancer Inst; 2017 Aug; 109(8):. PubMed ID: 28376197
[TBL] [Abstract][Full Text] [Related]
6. Human Papillomavirus 16 E6 Antibodies in Individuals without Diagnosed Cancer: A Pooled Analysis.
Lang Kuhs KA; Anantharaman D; Waterboer T; Johansson M; Brennan P; Michel A; Willhauck-Fleckenstein M; Purdue MP; Holcátová I; Ahrens W; Lagiou P; Polesel J; Simonato L; Merletti F; Healy CM; Kjaerheim K; Conway DI; Macfarlane TV; Thomson P; Castellsagué X; Znaor A; Black A; Huang WY; Krogh V; Trichopoulou A; Bueno-de-Mesquita HB; Clavel-Chapelon F; Weiderpass E; Ekström J; Riboli E; Tjønneland A; Sánchez MJ; Travis RC; Hildesheim A; Pawlita M; Kreimer AR
Cancer Epidemiol Biomarkers Prev; 2015 Apr; 24(4):683-9. PubMed ID: 25623733
[TBL] [Abstract][Full Text] [Related]
7. Association between human papillomavirus and oral cancer: a literature review.
Shigeishi H
Int J Clin Oncol; 2023 Aug; 28(8):982-989. PubMed ID: 36929094
[TBL] [Abstract][Full Text] [Related]
8. Naive and radiolabeled antibodies to E6 and E7 HPV-16 oncoproteins show pronounced antitumor activity in experimental cervical cancer.
Phaëton R; Gutierrez J; Jiang Z; Karabakhtsian RG; Albanese J; Sunkara J; Fisher DR; Goldberg GL; Dadachova E
Immunotherapy; 2015; 7(6):631-40. PubMed ID: 26098137
[TBL] [Abstract][Full Text] [Related]
9. Absence of high-risk HPV 16 and 18 in Chinese patients with oral squamous cell carcinoma and oral potentially malignant disorders.
Chen XJ; Sun K; Jiang WW
Virol J; 2016 May; 13():81. PubMed ID: 27206495
[TBL] [Abstract][Full Text] [Related]
10. Characterization of human papillomavirus (HPV) 16 E6 seropositive individuals without HPV-associated malignancies after 10 years of follow-up in the UK Biobank.
Brenner N; Mentzer AJ; Hill M; Almond R; Allen N; Pawlita M; Waterboer T
EBioMedicine; 2020 Dec; 62():103123. PubMed ID: 33248371
[TBL] [Abstract][Full Text] [Related]
11. Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer.
Ferreiro-Iglesias A; McKay JD; Brenner N; Virani S; Lesseur C; Gaborieau V; Ness AR; Hung RJ; Liu G; Diergaarde B; Olshan AF; Hayes N; Weissler MC; Schroeder L; Bender N; Pawlita M; Thomas S; Pring M; Dudding T; Kanterewicz B; Ferris R; Thomas S; Brhane Y; Díez-Obrero V; Milojevic M; Smith-Byrne K; Mariosa D; Johansson MJ; Herrero R; Boccia S; Cadoni G; Lacko M; Holcátová I; Ahrens W; Lagiou P; Lagiou A; Polesel J; Simonato L; Merletti F; Healy CM; Hansen BT; Nygård M; Conway DI; Wright S; Macfarlane TV; Robinson M; Alemany L; Agudo A; Znaor A; Amos CI; Waterboer T; Brennan P
Nat Commun; 2021 Oct; 12(1):5945. PubMed ID: 34642315
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus is a favourable prognostic factor in tonsillar cancer and its oncogenic role is supported by the expression of E6 and E7.
Lindquist D; Romanitan M; Hammarstedt L; Näsman A; Dahlstrand H; Lindholm J; Onelöv L; Ramqvist T; Ye W; Munck-Wikland E; Dalianis T
Mol Oncol; 2007 Dec; 1(3):350-5. PubMed ID: 19383307
[TBL] [Abstract][Full Text] [Related]
13. Murine HPV16 E7-expressing transgenic skin effectively emulates the cellular and molecular features of human high-grade squamous intraepithelial lesions.
Tuong ZK; Noske K; Kuo P; Bashaw AA; Teoh SM; Frazer IH
Papillomavirus Res; 2018 Jun; 5():6-20. PubMed ID: 29807614
[TBL] [Abstract][Full Text] [Related]
14. Potentially novel options for treatment of HPV-attributable head and neck cancer.
Brakenhoff RH
Cell Cycle; 2013 Apr; 12(7):1020-1. PubMed ID: 23511169
[No Abstract] [Full Text] [Related]
15. Detection of serum biomarkers of HPV-16 driven oropharynx and oral cavity cancer in Brazil.
Sichero L; Gonçalves MG; Bettoni F; Coser EM; Mota G; Nunes RAL; Mercante AMDC; Natalino R; Uno M; Ferreira Alves MJ; Matos LL; Kowalski LP; Kulcsar MAV; de Alvarenga GF; Höfler D; Schroeder L; Waterboer T; Tommasino M; Villa LL
Oral Oncol; 2024 Feb; 149():106676. PubMed ID: 38150987
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus E5 suppresses immunity via inhibition of the immunoproteasome and STING pathway.
Miyauchi S; Kim SS; Jones RN; Zhang L; Guram K; Sharma S; Schoenberger SP; Cohen EEW; Califano JA; Sharabi AB
Cell Rep; 2023 May; 42(5):112508. PubMed ID: 37171962
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of human papillomavirus in 45 greek patients with oral cancer.
Kouvousi M; Xesfyngi D; Tsimplaki E; Argyri E; Ioannidou G; Ploxorou M; Lazaris AC; Patsouris E; Panotopoulou E
J Oncol; 2013; 2013():756510. PubMed ID: 23533409
[TBL] [Abstract][Full Text] [Related]
18. Serum IgG antibodies to HPV6 L1, E2, E4, E6, and E7 proteins among children prospectively followed-up for three years.
Suominen H; Syrjänen K; Waterboer T; Grénman S; Syrjänen S; Louvanto K
J Infect Dis; 2024 May; ():. PubMed ID: 38820118
[TBL] [Abstract][Full Text] [Related]
19. MMP2 as an independent prognostic stratifier in oral cavity cancers.
Hoffmann C; Vacher S; Sirven P; Lecerf C; Massenet L; Moreira A; Surun A; Schnitzler A; Klijanienko J; Mariani O; Jeannot E; Badois N; Lesnik M; Choussy O; Le Tourneau C; Guillot-Delost M; Kamal M; Bieche I; Soumelis V
Oncoimmunology; 2020 May; 9(1):1754094. PubMed ID: 32934875
[TBL] [Abstract][Full Text] [Related]
20. HPV involvement in OSCC: Correlation of PCR results with light microscopic features.
Khangura RK; Sengupta S; Sircar K; Sharma B; Singh S; Rastogi V
J Oral Maxillofac Pathol; 2013 May; 17(2):195-200. PubMed ID: 24250078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
